Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01436604 | Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging(MRTOX) | terminated | Phase 2 | 19 | Centre Francois BaclesseOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT00041470 | Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial | terminated | Phase 1 / Phase 2 | 38 | University of WashingtonOTHER | 1 | Jul 17, 2017 |
| clinicaltrials |
| NCT00194792 | Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer | terminated | Phase 2 | 28 | University of WashingtonOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT01754519 | Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery | terminated | Phase 2 | 1 | Roswell Park Cancer InstituteOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT01918306 | GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 11 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT01868503 | Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer | terminated | Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00088985 | Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 56 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 20, 2017 | clinicaltrials |
| NCT00932035 | Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 39 | City of Hope Medical CenterOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT02322853 | A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors(OLYMPE) | terminated | Phase 2 | 8 | Centre Francois BaclesseOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT00661531 | Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy | terminated | Phase 2 | 11 | Georgetown UniversityOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01151449 | Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 11, 2017 | clinicaltrials |
| NCT01729884 | Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer | terminated | Phase 2 | 3 | University of WashingtonOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00126451 | A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) | terminated | Phase 2 | 16 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 10, 2017 | clinicaltrials |
| NCT00176488 | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | terminated | Phase 2 | 31 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00549822 | Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer | terminated | Phase 2 | 3 | Massachusetts General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00496366 | Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer | terminated | Phase 2 | 11 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT00285857 | Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention | terminated | Phase 2 | 30 | Stanford UniversityOTHER | 1 | Mar 9, 2017 | clinicaltrials |
| NCT01120158 | Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer | terminated | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01562873 | Ruxolitinib in Patients With Breast Cancer | terminated | Phase 2 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00904423 | Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption | terminated | Phase 1 / Phase 2 | 8 | Mark PegramOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT00133796 | Neoadjuvant Herceptin in Patients With Breast Cancer | terminated | Phase 2 | 40 | Mothaffar RimawiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00481845 | Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer | terminated | Phase 2 | 1 | Stanford UniversityOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02273752 | Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer | terminated | Phase 2 | 2 | Emory UniversityOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00096109 | Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2017 | clinicaltrials |
| NCT00045591 | Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer | terminated | Phase 2 | 39 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT02213744 | MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients(HERMIONE) | terminated | Phase 2 / Phase 3 | 113 | Merrimack PharmaceuticalsINDUSTRY | 9 | Jan 6, 2017 | clinicaltrials |
| NCT01708798 | Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer | terminated | Phase 2 / Phase 3 | 44 | University of British ColumbiaOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT00752986 | ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial(ZACFAST) | terminated | Phase 2 | 39 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT00977379 | A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis(XERAD) | terminated | Phase 2 | 24 | Hoffmann-La RocheINDUSTRY | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02645175 | Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue | terminated | Phase 2 | 3 | Meriyana Bio Inc.INDUSTRY | 0 | Oct 21, 2016 | clinicaltrials |
| NCT01194869 | Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer | terminated | Phase 2 | 25 | Emory UniversityOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT01910844 | Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes(META2) | terminated | Phase 2 | 3 | Centre Jean PerrinOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT01498588 | Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer | terminated | Phase 2 | 7 | Emory UniversityOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT00603408 | Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer | terminated | Phase 2 | 5 | Washington University School of MedicineOTHER | 1 | Aug 19, 2016 | clinicaltrials |
| NCT01132664 | Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer | terminated | Phase 1 / Phase 2 | 72 | Novartis PharmaceuticalsINDUSTRY | 6 | Aug 17, 2016 | clinicaltrials |
| NCT00427427 | Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer | terminated | Phase 2 | 75 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT01528345 | Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer | terminated | Phase 2 | 97 | Novartis PharmaceuticalsINDUSTRY | 15 | Jul 11, 2016 | clinicaltrials |
| NCT01339000 | Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | terminated | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00567879 | A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab | terminated | Phase 1 / Phase 2 | 56 | Novartis PharmaceuticalsINDUSTRY | 6 | May 9, 2016 | clinicaltrials |
| NCT00773474 | Lonafarnib in Metastatic Breast Cancer | terminated | Phase 2 | 29 | George SledgeOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | terminated | Phase 2 | 7 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01029925 | Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL) | terminated | Phase 2 | 7 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 12, 2016 | clinicaltrials |
| NCT01534455 | Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA) | terminated | Phase 2 | 43 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT00824733 | Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 6 | Bhuvaneswari RamaswamyOTHER | 1 | Jan 14, 2016 | clinicaltrials |
| NCT00347438 | Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer | terminated | Phase 2 | 18 | University of ChicagoOTHER | 2 | Dec 14, 2015 | clinicaltrials |
| NCT00636441 | Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer | terminated | Phase 2 | 56 | Duke UniversityOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT00216047 | PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 7 | Hoosier Cancer Research NetworkOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT00777335 | Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 4 | Translational Research in OncologyOTHER | 1 | Nov 24, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2017source: clinicaltrials